Patents Assigned to Optinose AS
-
Patent number: 8550073Abstract: A nasal delivery device for and method of delivering substance to a nasal cavity of a subject, the delivery device comprising: a nosepiece unit (20, 24) including a nosepiece (17) for fitting to a nostril of a subject and a nozzle (45) through which substance is in use delivered, preferably substantially axially to a longitudinal axis of the nosepiece, to the respective nasal cavity, wherein at least a tip element of the nosepiece has, at least in one configuration, an elongate lateral section which has a longer dimension in a first, sagittal direction than a second direction orthogonal to the sagittal direction, such that, when the nosepiece is inserted in the nasal cavity of the subject, the longer dimension of the nosepiece acts to engage lower and upper surfaces of the nasal cavity, preferably at the nasal valve, and expand the same in the sagittal plane; and a delivery unit (43, 49, 51) for delivering substance through the nozzle of the nosepiece.Type: GrantFiled: March 6, 2007Date of Patent: October 8, 2013Assignee: OptiNose ASInventor: Per Gisle Djupesland
-
Patent number: 8522778Abstract: A nasal delivery device for and a method of delivering a substance to a nasal cavity of a subject, the delivery device including: a nosepiece for fitting to a nostril of a subject; a substance supply unit for supplying a substance for delivery through the nosepiece; and a delivery prevention mechanism for preventing delivery of a substance through the nosepiece until the nosepiece is properly fitted to the nostril of the subject.Type: GrantFiled: April 9, 2010Date of Patent: September 3, 2013Assignee: OptiNose ASInventor: Per Gisle Djupesland
-
Patent number: 8511303Abstract: An exhalation breath-actuated nasal deliver device for and a method of delivering a substance to a nasal cavity of a subject, the delivery device comprising: a nosepiece for fitting to a nostril of a subject; a mouthpiece through which the subject in use exhales; and delivery unit, as one of a mechanical delivery pump or a nebulizer, for delivering a substance to the nosepiece; and an actuation mechanism for actuating the delivery unit in response to oral exhalation through the mouthpiece, and preferably when at least one or both of the pressure at or the flow rate through the nosepiece exceeds a predetermined threshold.Type: GrantFiled: December 21, 2007Date of Patent: August 20, 2013Assignee: Optinose ASInventor: Per Gisle Djupesland
-
Publication number: 20130125889Abstract: A breath-actuated delivery device includes a mouthpiece through which a subject in use exhales, an air channel which is in fluid communication with the mouthpiece, and a flexible diaphragm which is disposed in the air channel. The diaphragm provides for at least a restricted air flow through the air channel until a predeterminable actuation pressure is developed in the mouthpiece, and, on generation of the predeterminable actuation pressure in the mouthpiece, provides for an air flow through the air channel.Type: ApplicationFiled: May 16, 2012Publication date: May 23, 2013Applicant: OPTINOSE ASInventors: Per Gisle Djupesland, Martin Joseph Murphy, Stuart Brian William Kay, Andrew Gordon Pocock
-
Publication number: 20130098362Abstract: A nasal delivery device for and method of delivering substance to a nasal cavity of a subject, the delivery device comprising: a container-receiving unit comprising a container chamber for receiving a substance-containing container which contains substance to be delivered to the nasal cavity of the subject, the container chamber including an inlet and an outlet; a nosepiece unit including a nosepiece for fitting to a nasal cavity of the subject and being in fluid communication with the outlet of the container chamber; a mouthpiece unit including a mouthpiece in fluid communication with the inlet of the container chamber and through which the subject in use exhales, such as to entrain substance from the container and deliver the same through the nosepiece; and moisture-mitigation means for mitigating an effect of moisture in an exhaled breath on the entrainment of substance from the container.Type: ApplicationFiled: May 14, 2012Publication date: April 25, 2013Applicant: OptiNose ASInventors: Per Gisle Djupesland, Roderick Peter Hafner, Colin David Sheldrake
-
Patent number: 8327844Abstract: A delivery device (20, 22) for and a method of delivering a substance to the nasal airway (1) of a subject, in particular the posterior region of the nasal airway, the delivery device comprising: a closure unit for causing the closure of the oropharyngeal velum of the subject; and a delivery unit for delivering a gas flow entraining a substance to one of the nostrils of the subject at such a driving pressure as to flow around the posterior margin of the nasal septum and out of the other nostril of the subject, wherein the delivery unit comprises a nosepiece (30, 40, 58, 82, 102, 132) which includes an outlet through which the gas flow is in use delivered to the one nostril and a sealing member for sealing the one nostril to the outlet such as in use to prevent the escape of the gas flow through the one nostril.Type: GrantFiled: March 30, 2004Date of Patent: December 11, 2012Assignee: OptiNose ASInventor: Per Gisle Djupesland
-
Publication number: 20120260915Abstract: A nasal delivery device and a method of delivering substance to a nasal airway of a subject can be used for mass treatment, especially mass vaccination. The delivery device can include an interface unit, as a replaceable unit, having at least one nosepiece unit for fitting to a respective nostril of a subject, a nozzle from which substance is in use delivered, and at least one delivery unit having a substance supply unit for delivering substance to the nozzle of the at least one nosepiece unit. The delivery device can also include an actuation unit for actuating the at least one delivery unit of the interface unit.Type: ApplicationFiled: September 25, 2011Publication date: October 18, 2012Applicant: OPTINOSE ASInventor: Per Gisle Djupesland
-
Patent number: 8171929Abstract: A delivery device for and method of delivering substance to a nasal airway of a subject, the delivery device comprising: at least one nosepiece unit (21) for insertion into one nasal cavity of a subject and comprising a nosepiece (25) for fitting to the respective nostril of the subject; and at least one delivery unit (23) which is operative to deliver a substance through the at least one nosepiece unit into the one nasal cavity of the subject, wherein the at least one delivery unit includes a substance supply unit (27) for delivering a substance and an actuation unit (29) which is operable to actuate the substance supply unit, either automatically or manually, in response to nasal exhalation or at least attempted nasal exhalation by the subject.Type: GrantFiled: February 14, 2007Date of Patent: May 8, 2012Assignee: OptiNose ASInventors: Per Gisle Djupesland, Keith McMurray Boden
-
Publication number: 20120090608Abstract: A delivery device for and method of delivering substance, the delivery device comprising: a delivery outlet from which substance is in use delivered; a gas chamber containing a gas and being of reducible volume, wherein a reduction in the volume of the gas chamber to a predeterminable volume acts to pressurize the contained gas to a predeterminable pressure; a seal element disposed between the gas chamber and the delivery outlet; and an opening mechanism configured, on reduction of the volume of the gas chamber to a predeterminable volume, to open the seal element, whereupon a gas flow from the gas chamber acts to deliver substance from the delivery outlet.Type: ApplicationFiled: May 2, 2011Publication date: April 19, 2012Applicant: OptiNose ASInventors: Per Gisle Djupesland, Matthew Egerton Young, Andrew Robert Fry, Christopher John Hurlstone
-
Patent number: 8146589Abstract: A nasal delivery device (11) for delivering substance to a nasal airway (1) of a subject, comprising: first and second nosepiece units (17, 19), each including a nosepiece (21, 23) for fitting to respective nostrils of a subject; at least one substance supply unit (13, 15) for supplying substance for delivery to the nasal airway (1) of the subject; and a valve unit (35, 37) for selectively fluidly connecting the at least one substance supply unit (13, 15) alternately to respective ones of the nosepiece units (17, 19).Type: GrantFiled: March 28, 2003Date of Patent: April 3, 2012Assignee: OptiNose ASInventor: Per Gisle Djupesland
-
Publication number: 20120073571Abstract: A breath-actuated nasal delivery device, comprising: a mouthpiece through which a user in use exhales to actuate the delivery device; a nosepiece for fitting to a nostril of the user through which a substance is in use delivered; a substance supply unit actuatable to deliver a dose of a substance through the nosepiece; a loading unit operable to load the substance supply unit with an actuation force; and a release mechanism for enabling actuation of the substance supply unit in response to exhalation by the user through the mouthpiece; wherein the release mechanism comprises a locking unit which is movable: between a locking configuration in which the substance supply unit is locked in a non-actuated position when loaded by the loading unit and a release configuration in which the substance supply unit is actuatable by the loading unit, and a trigger member for releasing the locking unit from the locking configuration to the release configuration in response to exhalation by the user through the mouthpiece anType: ApplicationFiled: November 29, 2010Publication date: March 29, 2012Applicant: OPTINOSE ASInventor: Per Gisle DJUPESLAND
-
Publication number: 20120006323Abstract: A nasal delivery device for and a method of delivering a substance, in particular one of a liquid, as a suspension or solution, or a powder containing a medicament, especially systemic or topical pharmaceuticals, or a vaccine to the nasal airway of a subject.Type: ApplicationFiled: July 11, 2011Publication date: January 12, 2012Applicant: OPTINOSE ASInventor: PER GISLE DJUPESLAND
-
Publication number: 20110318345Abstract: substances and the nasal administration thereof, in particular as one of a liquid, as a suspension or solution, or a powder, to the nasal airway of a subject, in particular the posterior region of the nasal airway, and in particular the upper posterior region of the nasal airway, which includes the olfactory bulb, in particular in the treatment of neurological conditions and disorders.Type: ApplicationFiled: September 15, 2009Publication date: December 29, 2011Applicant: OptiNose ASInventor: Per Gisle Djupesland
-
Patent number: 8047202Abstract: A nasal delivery device and a method of delivering substance to a nasal airway of a subject, can be used for mass treatment, especially mass vaccination. The delivery device can include an interface unit, as a replaceable unit, having at least one nosepiece unit for fitting to a respective nostril of a subject, a nozzle from which substance is in use delivered, and at least one delivery unit having a substance supply unit for delivering substance to the nozzle of the at least one nosepiece unit. The delivery device can also include an actuation unit for actuating the at least one delivery unit of the interface unit.Type: GrantFiled: December 19, 2008Date of Patent: November 1, 2011Assignee: OptiNose ASInventor: Per Gisle Djupesland
-
Publication number: 20110259329Abstract: A breath-actuated delivery device includes a mouthpiece through which a subject in use exhales, an air channel which is in fluid communication with the mouthpiece, and a flexible diaphragm which is disposed in the air channel. The diaphragm provides for at least a restricted air flow through the air channel until a predeterminable actuation pressure is developed in the mouthpiece, and, on generation of the predeterminable actuation pressure in the mouthpiece, provides for an air flow through the air channel.Type: ApplicationFiled: August 30, 2010Publication date: October 27, 2011Applicant: OptiNose ASInventors: Per Gisle Djupesland, Martin Joseph Murphy, Stuart Brian William Kay, Andrew Gordon Pocock
-
Patent number: 7975690Abstract: The present invention relates to a nasal delivery device for and a method of delivering a substance, in particular one of a liquid, as a suspension or solution, or a powder containing a medicament, especially systemic or topical pharmaceuticals, or a vaccine to the nasal airway of a subject.Type: GrantFiled: June 12, 2002Date of Patent: July 12, 2011Assignee: OptiNose ASInventor: Per Gisle Djupesland
-
Publication number: 20110126830Abstract: A delivery device for delivering a metered amount of substance, the delivery device comprising: a mouthpiece (17) through which a user in use exhales; an outlet (19) through which substance is in use delivered; a housing (21) fluidly connected to the mouthpiece and the outlet, such, that exhalation by the user through the mouthpiece creates an air flow through the housing and from the outlet; and a substance-dispensing unit (25) which is disposed within the housing and operative to dispense a metered amount of substance into an entraining air flow as created through the housing.Type: ApplicationFiled: November 28, 2007Publication date: June 2, 2011Applicant: OPTINOSE ASInventor: Per Gisle Djupesland
-
Patent number: 7934503Abstract: A delivery device for and method of delivering substance, the delivery device comprising: a delivery outlet (7) from which substance (S) is in use delivered; a gas chamber (17) containing a gas and being of reducible volume, wherein a reduction in the volume of the gas chamber (17) to a predeterminable volume acts to pressurize the contained gas to a predeterminable pressure; a seal element (11) disposed between the gas chamber (17) and the delivery outlet (7); and an opening mechanism configured, on reduction of the volume of the gas chamber to a predeterminable volume, to open the seal element (11), whereupon a gas flow from the gas chamber (17) acts to deliver substance (S) from the delivery outlet (7).Type: GrantFiled: July 9, 2003Date of Patent: May 3, 2011Assignee: Optinose ASInventors: Per Gisle Djupesland, Matthew Egerton Young, Andrew Robert Fry, Christopher John Hurlstone
-
Publication number: 20110088690Abstract: A nasal delivery device for and a method of delivering substance to a nasal airway of a subject, the nasal delivery device comprising : a mouthpiece (519) through which the subject in use exhales to cause closure of the oropharyngeal velum of the subject; a nosepiece (517) for fitting to a nostril of a subject, the nosepiece including a nozzle (549) through which substance is in use delivered to the nasal airway; and a manually-actuatable substance supply unit (520) for delivering substance through the nozzle of the nosepiece.Type: ApplicationFiled: October 3, 2008Publication date: April 21, 2011Applicant: OPTINOSE ASInventors: Per Gisle Djupesland, Colin David Sheldrake
-
Publication number: 20110053827Abstract: Intranasal administration of proteins, such as insulin and insulin analogues, in particular immunogenic proteins to the upper posterior region of a nasal cavity of a subject, and in particular the olfactory bulb region.Type: ApplicationFiled: June 8, 2007Publication date: March 3, 2011Applicant: OPTINOSE ASInventor: Roderick Peter Hafner